← All indications
Measles
A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM.
Subtype terms (1)
More specific conditions that are subtypes of Measles in the MeSH hierarchy.
Drugs by status
Approved for this indication (11)
- attenuated measles vaccine - Edmonston strain
- measles and inactivated polio vaccine
- measles-rubella vaccine
- rubeola (measles) gamma globulin (human)
- vitamin a
- M-Vac
- inactivated measles vaccine
- rubeola (measles) virus vaccine, inactivated, Morten strain
- attenuated measles virus vaccine (Moraten)
- live virus measles vaccine
- attenuated measles virus vaccine
Phase 4 trials (11)
- bacille calmette-guerin
- hepatitis a vaccine, inactivated
- inactivated japanese encephalitis vaccine
- human papillomavirus 9-valent vaccine, recombinant
- live oral poliovirus type 1, 2 and 3
- measles, mumps, rubella, varicella vaccine
- measles, mumps, and rubella vaccine
- inactivated varicella vaccine
- human rotavirus, live attenuated
- inactivated SARS-Cov-2 vaccine
- Inactivated polio virus - Enhanced
Phase 3 trials (16)
- albumin (Human)
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- pneumococcal 13-valent conjugate vaccine
- Measles, Mumps and Rubella Vaccine, Live
- typhoid vi polysaccharide vaccine
- sulfamethoxazole
- yellow fever vaccine 17d strain
- Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
- live attenuated varicella vaccine
- killed oral cholera vaccine
- pneumococcal 7-valent conjugate vaccine
- v221
- meningococcal (groups A, C, Y, W) tetanus toxoid conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- bivalent oral polio vaccine (bopv), type 1 and type 3
- trimethoprim
Phase 2 trials (6)
Organizations
Organization Involved with Phase 4 Indications (36)
- Merck
- Novo Nordisk
- Sanofi
- Sanofi-Aventis
- GlaxoSmithKline
- INC Research
- PT Bio Farma
- Bandim Health Project
- Centers for Disease Control and Prevention, China
- Maastricht University
- University of Groningen
- University of Heidelberg
- Utrecht University
- Navrongo Health Research Centre, Ghana
- Statens Serum Institut
- Leiden University
- Free University of Amsterdam
- University of the Witwatersrand
- International Center for Diarrheal Disease Research
- Government of China
- Medical Research Council, The Gambia
- University of Paris
- Erasmus University Rotterdam
- Centre de Recherche en Sante de Nouna, Burkina Faso
- Government of Bangladesh
- AP Moeller Foundation
- Beijing Tiantan Bio Co., Ltd
- National Institute for Public Health and the Environment, RIVM, Holland
- Institudo Nacional de Saude Publica INASA
- Danish Council for Development Research
- +6 more
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (5)